IDRA-21 Powder

A. Introduction

IDRA‑21 Powder is a high‑purity, lyophilized small‑molecule material intended for analytical and neuroscience‑oriented research workflows. This product is positioned for use in controlled laboratory environments where precise weighing, formulation, and documented handling are required, with all language and framing confined strictly to research‑context use rather than any consumer‑facing cognitive‑enhancement or “smart‑drug” claims.

B. Scientific Overview

IDRA‑21 (CAS 22503‑72‑6, 7‑chloro‑3‑methyl‑3,4‑dihydro‑2H‑1,2,4‑benzothiadiazine 1,1‑dioxide) is a positive allosteric modulator of AMPA‑type glutamate receptors that appears in pharmacological and neuroscience literature as a tool compound for studying synaptic plasticity, excitatory neurotransmission, and cognitive‑related pathways. For compliance‑safe SEO and product positioning, it should be described neutrally as IDRA‑21 Powder and as a RUO research compound, without any reference to memory, focus, learning, or other human‑outcome benefits.

C. Product Specifications

• Form: Lyophilized powder.

• Chemical name: 7‑chloro‑3‑methyl‑3,4‑dihydro‑2H‑1,2,4‑benzothiadiazine 1,1‑dioxide.

• CAS Number: 22503‑72‑6.

• Molecular formula: C₈H₉ClN₂O₂S.

• Approx. molecular weight: ~232.7 g/mol.

• Classification: Research Use Only (RUO).

• Product Type: IDRA‑21 Powder research chemical.

• Purity: High‑purity, analytically verified (commonly ≥99% by HPLC or LC‑MS where documented).

• Storage: Store in a cool, dry place, protected from light and moisture; keep containers tightly sealed.

D. Laboratory Use Context

This product is intended for in‑vitro, cell‑based, and receptor‑modulation research conducted in controlled laboratory settings, particularly in neuroscience and pharmacology studies involving AMPA‑type glutamate receptors and synaptic plasticity. It must be clearly presented as unsuitable for human consumption, clinical use, or self‑experimentation and should not be described as a dietary, nootropic, or neuroprotective supplement for personal use.

E. Quality & Testing

Each batch should be supported by documented quality‑assurance practices that promote reproducibility, traceability, and analytical consistency, including batch tracking, identity verification, purity data, and coa‑style documentation where applicable. These elements strengthen E‑E‑A‑T signals by supporting transparent, professional‑grade, research‑oriented positioning suitable for reference‑standard and method‑development work.

F. Shipping & Handling

Orders are typically supplied in small grammage vials or sealed bags and shipped worldwide using secure handling practices that maintain powder integrity. The shipping narrative should remain neutral and technical, emphasizing packaging protection, environmental control, and secure fulfillment, without implying any human‑use‑driven or wellness‑oriented purpose.

G. Compliance Disclaimer

For Research Use Only. Not for human consumption.
This product is sold strictly for lawful analytical and laboratory research by qualified purchasers where permitted under local, national, and international regulations. By purchasing, the buyer acknowledges responsibility for compliance with all applicable laws and understands that no medical, therapeutic, or consumer‑related claims are made or implied.